Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.64) by 31.87 percent. This is a 84.86 percent increase over losses of $(5.55) per share from the same period last year. The company reported quarterly sales of $28.874 million which beat the analyst consensus estimate of $26.650 million by 8.35 percent. This is a 2.01 percent decrease over sales of $29.467 million the same period last year.